← Open Payments lookup

ADAM BIUCKIANS: Open Payments

NPI 1558342402 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,132 in 58 payments from 9 companies in 2025. Trend: 2023 $1,395 · 2024 $1,083 · 2025 $1,132

Food & beverage: $1,030Education: $101
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.26$387
Supernus Pharmaceuticals, Inc.13$302
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$215
Otsuka America Pharmaceutical, Inc.4$89
Neurocrine BioSciences, Inc.2$42
Janssen Pharmaceuticals, Inc1$37
Alkermes, Inc.1$22
Takeda Pharmaceuticals U.S.A., Inc.1$20
Lundbeck LLC1$17

Products named: Qelbree, CAPLYTA, UZEDY, AUSTEDO XR, ABILIFY ASIMTUFII, INGREZZA, REXULTI, INVEGA SUSTENNA.

Industry payments across PA — which companies pay providers there.